Insulin syringes recalled because of potential injury to patients

Nipro Medical Corporation, makers of diabetic syringes, is initiating a nationwide recall of all GlucoPro Insulin Syringes because the syringes have needles that detach from the syringe. If the needle becomes detached during use, it can become stuck in the insulin vial, push back into the syringe, or remain in the skin after injection.

The GlucoPro recall comes just months after a similar recall by Qualitest Pharmaceuticals Inc., of its Accusure Insulin Syringes. Qualitest Pharmaceuticals issued its recall on some of its syringes in August 2009, and expanded it in October 2009 to include all lots of the Accusure Insulin Syringes.

The Nipro Medical recall includes all GlucoPro Insulin Syringes, but does not involve the GlucoPro syringe specific for use with the Amigo Insulin pump. The recalled syringes, which were distributed throughout the U.S. and Puerto Rico, include all product codes and lot numbers with expiration dates before 2011-11 (Nov. 1, 2011). The Food and Drug Administration (FDA) has been made aware of this recall.  To date, no injuries associated with the use of the syringes have been reported.

Nipro Medical is notifying its distributors and customers by fax and e-mail, and is arranging for return of all recalled products. Consumers with questions may call the company at 305-599-7174, extension 249. Any adverse reactions with this or any other product may be reported to the FDA’s Medwatch Adverse Events Reporting Program at